JP2013518925A5 - - Google Patents

Download PDF

Info

Publication number
JP2013518925A5
JP2013518925A5 JP2012552884A JP2012552884A JP2013518925A5 JP 2013518925 A5 JP2013518925 A5 JP 2013518925A5 JP 2012552884 A JP2012552884 A JP 2012552884A JP 2012552884 A JP2012552884 A JP 2012552884A JP 2013518925 A5 JP2013518925 A5 JP 2013518925A5
Authority
JP
Japan
Prior art keywords
abdnaz
solvent
dnaz
dichloromethane
reaction mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012552884A
Other languages
English (en)
Japanese (ja)
Other versions
JP5461712B2 (ja
JP2013518925A (ja
Filing date
Publication date
Priority claimed from US12/702,782 external-priority patent/US8471041B2/en
Application filed filed Critical
Publication of JP2013518925A publication Critical patent/JP2013518925A/ja
Publication of JP2013518925A5 publication Critical patent/JP2013518925A5/ja
Application granted granted Critical
Publication of JP5461712B2 publication Critical patent/JP5461712B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012552884A 2010-02-09 2011-01-18 N−(ブロモアセチル)−3,3−ジニトロアゼチジンの合成及び単離法並びにそれを含む組成物 Active JP5461712B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/702,782 US8471041B2 (en) 2010-02-09 2010-02-09 Methods of synthesizing and isolating N-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same
US12/702,782 2010-02-09
PCT/US2011/021500 WO2011100090A1 (en) 2010-02-09 2011-01-18 Methods of synthesizing and isolating n-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same

Publications (3)

Publication Number Publication Date
JP2013518925A JP2013518925A (ja) 2013-05-23
JP2013518925A5 true JP2013518925A5 (https=) 2013-08-29
JP5461712B2 JP5461712B2 (ja) 2014-04-02

Family

ID=43875262

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012552884A Active JP5461712B2 (ja) 2010-02-09 2011-01-18 N−(ブロモアセチル)−3,3−ジニトロアゼチジンの合成及び単離法並びにそれを含む組成物

Country Status (12)

Country Link
US (1) US8471041B2 (https=)
EP (1) EP2534131B1 (https=)
JP (1) JP5461712B2 (https=)
KR (1) KR101456438B1 (https=)
CN (1) CN102762535B (https=)
AU (1) AU2011216176B2 (https=)
CA (1) CA2788459C (https=)
DK (1) DK2534131T3 (https=)
ES (1) ES2460040T3 (https=)
IL (1) IL221141A (https=)
MX (1) MX2012008989A (https=)
WO (1) WO2011100090A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070135380A1 (en) 2005-08-12 2007-06-14 Radiorx, Inc. O-nitro compounds, pharmaceutical compositions thereof and uses thereof
US7507842B2 (en) 2005-08-12 2009-03-24 Radiorx, Inc. Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
US8664247B2 (en) 2011-08-26 2014-03-04 Radiorx, Inc. Acyclic organonitro compounds for use in treating cancer
US20140308260A1 (en) 2011-10-07 2014-10-16 Radiorx, Inc. Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products
CA2850723C (en) 2011-10-07 2019-07-09 Radiorx, Inc. Organonitro thioether compounds and medical uses thereof
US10342778B1 (en) 2015-10-20 2019-07-09 Epicentrx, Inc. Treatment of brain metastases using organonitro compound combination therapy
US9987270B1 (en) 2015-10-29 2018-06-05 Epicentrix, Inc. Treatment of gliomas using organonitro compound combination therapy
CN109069420A (zh) 2016-01-11 2018-12-21 埃皮辛特瑞柯斯公司 2-溴-1-(3,3-二硝基氮杂环丁烷-1-基)乙酮静脉施用的组合物和方法
SG11201903312VA (en) 2016-10-14 2019-05-30 Epicentrix Inc Sulfoxyalkyl organonitro and related compounds and pharmaceutical compositions for use in medicine
EP3648740A1 (en) 2017-07-07 2020-05-13 EpicentRx, Inc. Compositions for parenteral administration of therapeutic agents
WO2019164593A2 (en) 2018-01-08 2019-08-29 Epicentrx, Inc. Methods and compositions utilizing rrx-001 combination therapy for radioprotection
BR112023025535A2 (pt) 2021-06-09 2024-02-27 Epicentrx Inc Composições de abdnaz cristalinas e métodos para fazer e usar as mesmas
WO2024145484A1 (en) 2022-12-29 2024-07-04 Epicentrx, Inc. Rrx-001 for treating reproductive-related disorders

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4935450A (en) 1982-09-17 1990-06-19 Therapeutical Systems Corporation Cancer therapy system for effecting oncolysis of malignant neoplasms
JPS60116642A (ja) 1983-11-29 1985-06-24 Nippon Kayaku Co Ltd 2−モノ−置換メチル−5,5−ジメチル−シクロ−2−ヘキセノン誘導体
GB8504253D0 (en) 1985-02-19 1985-03-20 Ici Plc Electrostatic spraying apparatus
GB8728418D0 (en) 1987-12-04 1988-01-13 Jenkins T C Nitro-substituted aromatic/hetero-aromatic compounds for use in cancer treatment
DE3815221C2 (de) 1988-05-04 1995-06-29 Gradinger F Hermes Pharma Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen
US5693794A (en) 1988-09-30 1997-12-02 The United States Of America As Represented By The Secretary Of The Navy Caged polynitramine compound
JP2659614B2 (ja) 1990-11-13 1997-09-30 株式会社日立製作所 表示制御装置
US5698155A (en) 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
US5336784A (en) 1993-06-07 1994-08-09 The Regents Of The University Of California Synthesis of 1,3,3-trinitroazetidine
JP3211892B2 (ja) 1994-05-27 2001-09-25 セイジィ ファーマスーティカルス インコーポレーテッド 肛門疾患を治療する窒素酸化物供与体及び方法
US5970974A (en) 1995-03-14 1999-10-26 Siemens Aktiengesellschaft Dosating unit for an ultrasonic atomizer device
DE69605025T2 (de) 1995-03-14 2000-07-20 Siemens Ag Ultraschallzerstäuber mit abnehmbarer präzisionsdosiereinheit
WO1996036602A1 (en) 1995-05-15 1996-11-21 The United States Of America Adnaz, compositions and processes
US5580988A (en) 1995-05-15 1996-12-03 The United States Of America As Represented By The Secretary Of The Army Substituted azetidines and processes of using them
US5898038A (en) 1996-03-19 1999-04-27 Board Of Regents, The University Of Texas System Treatment of osteoporosis and metabolic bone disorders with nitric oxide substrate and/or donors
IL128589A0 (en) 1996-10-15 2000-01-31 Eastman Chem Co Explosive formulations
GB9720797D0 (en) 1997-09-30 1997-12-03 Rhodes John Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
US5954047A (en) 1997-10-17 1999-09-21 Systemic Pulmonary Development, Ltd. Methods and apparatus for delivering aerosolized medication
US6056966A (en) 1998-05-18 2000-05-02 Baker Norton Pharmaceuticals, Inc. Method and compositions for treating impotence
EP1098641B1 (en) 1998-07-27 2016-04-27 St. Jude Pharmaceuticals, Inc. Chemically induced intracellular hyperthermia
US6448253B1 (en) 1998-09-16 2002-09-10 King Pharmaceuticals Research And Development, Inc. Adenosine A3 receptor modulators
US6245799B1 (en) 1999-11-08 2001-06-12 American Home Products Corp [(Indol-3-yl)-cycloalkyl]-3-substituted azetidines for the treatment of central nervous system disorders
PL358623A1 (en) 2000-04-10 2004-08-09 Pfizer Products Inc. Benzoamide piperidine compounds as substance p antagonists
US6861530B2 (en) 2000-07-07 2005-03-01 Kyowa Hakko Kogyo Co., Ltd. Piperidine derivatives
DE10111049A1 (de) 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthese des warmblütigen Organismus ihre Wirkung entfaltet, zur Herstellung von kosmetischen oder dermatologischen Zubereitungen, zur Prophylaxe und Behandlung von entzündlichen Hautzuständen und/oder zum Hautschutz bei empfindlich determinierter trockener Haut
EP1336602A1 (en) 2002-02-13 2003-08-20 Giovanni Scaramuzzino Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
CA2491127A1 (en) 2002-07-03 2004-01-15 Nitromed, Inc. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
US20040167212A1 (en) 2002-10-07 2004-08-26 Bednarski Mark D. X-nitro compounds, pharmaceutical compositions thereof and uses thereof
US6870061B2 (en) 2003-01-10 2005-03-22 Alliant Techsystems Inc. Continuous process and system for production of glycidyl nitrate from glycerin, nitric acid and caustic and conversion of glycidyl nitrate to poly(glycidyl nitrate)
EP1603933A2 (en) 2003-03-13 2005-12-14 Nitromed, Inc. Nitrosated and nitrosylated compounds, compositions and methods of use
ATE500216T1 (de) 2003-06-25 2011-03-15 Je Il Pharmaceutical Co Ltd Tricyclische derivate oder pharmazeutisch unnbedenkliche salze davon, deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten
GB0326047D0 (en) 2003-11-07 2003-12-10 Univ Sheffield Substance
EP1791544A4 (en) 2004-09-08 2007-09-12 Chelsea Therapeutics Inc CHINAZOLINE DERIVATIVES AS METABOLIC INERT ANTIFOLATE
US7507842B2 (en) * 2005-08-12 2009-03-24 Radiorx, Inc. Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
US20070135380A1 (en) 2005-08-12 2007-06-14 Radiorx, Inc. O-nitro compounds, pharmaceutical compositions thereof and uses thereof
JP2009510073A (ja) 2005-09-27 2009-03-12 ノバルティス アクチエンゲゼルシャフト カルボキシアミン化合物およびその使用方法
KR100967848B1 (ko) * 2008-05-28 2010-07-05 국방과학연구소 분자화약이 도입된, 고에너지 결합제용1-글리시딜-3,3-디니트로아제티딘 및 그의 제조방법
WO2012078992A1 (en) 2010-12-09 2012-06-14 Radiorx, Inc. Organonitro compounds for use in treating non-hodgkin's lymphoma and leukemia, and methods relating thereto

Similar Documents

Publication Publication Date Title
JP2013518925A5 (https=)
JP2018502909A5 (https=)
JP2008507566A5 (https=)
RU2021125455A (ru) Твердые формы { [5-(3-хлорфенил)-3-гидроксипиридин-2-карбонил]амино} уксусной кислоты, их композиции и применения
JP5390617B2 (ja) アデホビルジピボキシルの精製方法
US10106489B2 (en) Process for the purification of polyaminocarboxylates
JP2009541290A5 (https=)
JP2015500325A5 (https=)
EP3109241B1 (en) Method of refining valsartan comprising more than 10% d-isomers
CN103467310B (zh) 一种(s)-1-氨基-3-氯-2-丙醇盐酸盐的分离纯化方法
CN108358961B (zh) 一种易纯化苯并氧杂硼杂戊环类抗真菌药物的制备方法
WO2016202252A1 (zh) 一种合成d-对羟基苯甘氨酸甲酯的方法
CN110872251A (zh) N-乙基吡啶甲胺三氟乙酸盐及其晶体、制备工艺和应用
CN107353250B (zh) 一种氯卡色林的合成方法
JP3902384B2 (ja) 光学活性α−メチル−ビス−3,5−(トリフルオロメチル)ベンジルアミン類の精製方法
KR20140028433A (ko) 플루복사민 자유 염기의 정제방법 및 이를 이용한 고순도 플루복사민 말레이트의 제조방법
CN105585524B (zh) 一种由孟鲁司特酸制备孟鲁司特钠的方法
CN105061219A (zh) 一种制备s-1-氨基茚满的方法
CN103922907B (zh) 一种金刚烷甲醛的制备方法
CN105924392B (zh) 一种孟鲁司特钠制备方法
CN103319358B (zh) 一种7-氨基庚酸的制备方法
WO2013159283A1 (zh) 一种制备(s)−奥拉西坦的方法
CN102603605B (zh) (s)-4-羟基-2-氧代-1-吡咯烷乙酰胺的制备方法
CN103087058A (zh) 一种回收内消旋环酸酐去对称化反应所用的催化剂奎宁的方法
CN105481831A (zh) 一种制备达比加群酯中间体的新方法